- Home
- CDTX vs BHR Comparison
CDTX vs BHR Comparison
Compare CDTX & BHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDTX
- BHR
- Stock Information
- Founded
- CDTX 2012
- BHR 2013
- Country
- CDTX United States
- BHR United States
- Employees
- CDTX N/A
- BHR N/A
- Industry
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- BHR Real Estate Investment Trusts
- Sector
- CDTX Health Care
- BHR Real Estate
- Exchange
- CDTX Nasdaq
- BHR Nasdaq
- Market Cap
- CDTX 207.4M
- BHR 209.5M
- IPO Year
- CDTX 2015
- BHR N/A
- Fundamental
- Price
- CDTX $21.54
- BHR $2.58
- Analyst Decision
- CDTX Strong Buy
- BHR Hold
- Analyst Count
- CDTX 7
- BHR 1
- Target Price
- CDTX $32.20
- BHR $2.50
- AVG Volume (30 Days)
- CDTX 91.1K
- BHR 166.7K
- Earning Date
- CDTX 11-07-2024
- BHR 02-26-2025
- Dividend Yield
- CDTX N/A
- BHR 7.75%
- EPS Growth
- CDTX N/A
- BHR N/A
- EPS
- CDTX N/A
- BHR N/A
- Revenue
- CDTX $44,653,000.00
- BHR $732,339,000.00
- Revenue This Year
- CDTX N/A
- BHR N/A
- Revenue Next Year
- CDTX N/A
- BHR N/A
- P/E Ratio
- CDTX N/A
- BHR N/A
- Revenue Growth
- CDTX 44.48
- BHR N/A
- 52 Week Low
- CDTX $10.00
- BHR $1.79
- 52 Week High
- CDTX $28.42
- BHR $3.95
- Technical
- Relative Strength Index (RSI)
- CDTX 48.34
- BHR 41.65
- Support Level
- CDTX $20.50
- BHR $2.59
- Resistance Level
- CDTX $24.95
- BHR $2.69
- Average True Range (ATR)
- CDTX 1.66
- BHR 0.11
- MACD
- CDTX 0.20
- BHR 0.02
- Stochastic Oscillator
- CDTX 50.36
- BHR 30.00
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.
About BHR Braemar Hotels & Resorts Inc.
Braemar Hotels & Resorts Inc is a real estate investment trust company that invests in high revenue per available room, or RevPAR, luxury, upper-upscale and upscale hotels in gateway and resort locations. The firm operates in various U.S. states such as California, Texas, Washington, Philadelphia, Florida, and Illinois as well as Washington, D.C. and St. Thomas, U.S. Virgin Islands. The company operates through its direct hotel investment segment. Its revenue streams include rooms, food and beverage, and other. The firm's hotels operate under various brands, such as Marriott, Hilton, Courtyard, and Renaissance, among others.